Read More Pharma Industry News SK Biopharmaceuticals launches phase 3 trial of seizures drug cenobamate in Asia SK Biopharmaceuticals, a South Korean pharma company, has revealed plans to initiate a phase 3 clinical trial for… bypharmanewsdailySeptember 12, 2020